LearnOptimizeInsightsSignalsInstitutional (Soon)Ask (Soon)Comparisons

Invesco Global Active ESG Equity UCITS ETF Acc | Invesco UK

Not currently available · IE00BJQRDN15 · Invesco

Overview

Invesco Global Active ESG Equity UCITS ETF Acc | Invesco UK tracks UK equities while applying ESG screening or transition criteria. It has a TER of 0.30% and reinvests income.

Key facts

Ticker
Not currently available
ISIN
IE00BJQRDN15
Provider
Invesco
TER (ongoing charge)
0.30%
Benchmark
MSCI World Total Return (Net) Index
Fund domicile
Ireland
UCITS status
ucits
Asset class
Equity
Category
Not currently available
Distribution
Accumulating
Fund currency
USD
Hedged
Not currently available

Benchmark & strategy

Benchmark
MSCI World Total Return (Net) Index
Index tracked
Not currently available
Replication
Not currently available

Costs & size

AUM
$3.3B
AUM currency
USD

Risk & fund structure

Launch date
31 Jul 2019
Replication method
Not currently available
Share class currency
USD
Currency exposure
Not currently available
SFDR
Not currently available

Official Documents

These primary-source links open on the ETF provider’s website.

Data provenance
Source: Not currently available
Source last checked: 26 Jul 2026
Record last updated: 26 Jul 2026
Enrichment status: imported

Continue researching

Related Grovcap guides, rankings and tools to take the next step.

Disclaimer

The information provided by Grovcap is for informational and educational purposes only and does not constitute investment, financial, legal, or tax advice. Investing involves risk, including the possible loss of capital. Always conduct your own research or consult a qualified professional before making investment decisions.

Your responses to quizzes, surveys, and other interactive features may be used in aggregated and anonymized form to improve Grovcap and generate investor insights. We do not sell personally identifiable information to third parties. For more information about how we collect, use, and protect your data, please refer to our Privacy Policy.